Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: MDI Healthcare CC, 374 Anderson Street, Menlo Park, Pretoria, 0081, RSA
DIPHAL EXPECTORANT (Solution).
| Pharmaceutical Form |
|---|
|
Solutions. A clear brown syrupy liquid. |
Each 5 ml contains:
Diphenhydramine Hydrochloride 14 mg
Ammonium Chloride 136 mg
Preservative: Nipastat 0,02% m/v
Contains sugar (sucrose) 1 300 mg per 5 ml.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ammonium chloride |
|
|
| Diphenhydramine |
Diphenhydramine is an ethanolamine-derivative antihistamine. It is an antihistamine with anticholinergic and marked sedative effects. It acts by inhibiting the effects on H1-receptors. Diphenhydramine is effective in reducing sleep onset (i.e., time to fall asleep) and increasing the depth and quality of sleep. |
| List of Excipients |
|---|
|
Caramel 4800 (flavour) |
100 ml round amber PVC bottles with white LDPE screw on or snap-on caps, or 200 ml round amber PVC bottles with white LDPE snap-on caps.
MDI Healthcare CC, 374 Anderson Street, Menlo Park, Pretoria, 0081, RSA
46/10.1/0087
Date of registration: 25 March 2019
| Drug | Countries | |
|---|---|---|
| DIPHAL EXPECTORANT | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
